Download
Discipline -
Clinical microbiology
Antifungal susceptibility testing for yeasts and filamentous fungi
Assay format
Manual techniques
Information History
First added in 2020
Changed in 2024
Purpose type
Aid to diagnosis
Purpose
Final step in selection of appropriate antifungals after species identification and interpretation by EUCAST and CLSI guidelines.
Specimen types
Fungal isolates
WHO prequalified or recommended products
N/A
GMDN
45299
Multiple antifungal susceptibility testing kit IVD
A collection of reagents and other associated materials containing multiple susceptibility testing discs impregnated with a range of antifungal/antimycotic agents (i.e., drugs intended for treatment and/or prevention of a fungal infection) intended to be used to determine the susceptibility profile of a specific fungal or yeast microorganism, isolated from a clinical specimen by culture.
The medical device term(s), code(s) and definition(s) in this section were retrieved from databases external to WHO. As there might be more than one name, definition and “Nomenclature Code” related to the specific medical device, please consult https://gmdnagency.org GMDN ®. © GMDN Agency 2005-2024EMDN
W01040805
MANUAL SUSCEPTIBILITY TESTING
The code(s) and term(s) in this section were observed and retrieved from public databases and have not been validated by health regulatory authorities. Please consult your regulatory agency and EMDN site: https://webgate.ec.europa.eu/dyna2/emdnWHO supporting publications
Essential package of in vitro diagnostic tests for bacterial and fungal infections, and AMR. 2025. (To be published)
Technical specifications
N/A
SAGE IVD recommended including this test in the EDL on the basis of the scientific validity of the analyte. It was recognized that the test is a foundational IVD test and is included in clinical guidelines.
N/A
The inclusion of this test was based on WHO guidelines and/or technical documents that include recommendations for the use of this test.
N/A